您好,欢迎访问中国水产科学研究院 机构知识库!

Antiangiogenic activity of low-temperature lysozyme from a marine bacterium in vivo and in vitro

文献类型: 外文期刊

作者: Wang Zhenhua 1 ; Liu Jincheng 1 ; Su Ai 1 ; Sun Mi 2 ; Wang Chunbo 1 ;

作者机构: 1.Qingdao Univ, Coll Med, Qingdao 266071, Peoples R China

2.Chinese Acad Fishery Sci, Yellow Sea Fisheries Res Inst, Qingdao 266071, Peoples R China

关键词: marine low-temperature lysozyme;antiangiogenesis;human umbilical vein endothelial cells;zebrafish embryo

期刊名称:CHINESE JOURNAL OF OCEANOLOGY AND LIMNOLOGY ( 2019影响因子:1.068; 五年影响因子:0.983 )

ISSN: 0254-4059

年卷期: 2009 年 27 卷 4 期

页码:

收录情况: SCI

摘要: We extracted marine low-temperature lysozyme (MLTL), a novel lysozyme, from a marine microorganism through fermentation. Our previous study suggested that a low molecular weight (16 kDa) may exert anti-tumor activity through antiangiogenesis. In this study, we extracted a high weight (39 kDa) and investigated its antiangiogenic activity in vivo and in vitro. Using zebrafish embryos as an in vivo study model, we found that treatment with MLTL significantly inhibited the growth of subintestinal vessels (SIVs) in a dose-dependent manner and that 400 A mu g/ml MLTL was sufficient to block the growth of SIVs. An in vitro study conducted using human umbilical vein endothelial cells (HUVECs) revealed that MLTL suppressed the proliferation, migration and tube formation of HUVECs in a dose-dependent manner. Interestingly, assays by flow cytometry and DNA electrophoresis indicated that MLTL was able to induce apoptosis of HUVECs. Moreover, further study demonstrated that the disruption of intracellular Ca(2+) homeostasis may play an important role in MLTL induced apoptosis of HUVECs. Taken together, the results of this study demonstrate for the first time that MLTL inhibits angiogenesis through its pleiotropic effects on vascular endothelial cells and induces apoptosis through regulation of cellular Ca(2+) levels. The results of this study also revealed a possible mechanism underlying the antiangiogenic effect of MLTL and suggested that MLTL may be a promising new antiangiogenic agent for use in cancer therapy.

  • 相关文献
作者其他论文 更多>>